News

Headlines and features from the Thoroughbred industry

Can Tiludronate be Used in Horse Joints?

Early in 2014, the U.S. Food and Drug Administration approved tiludronate for intravenous administration in horses with navicular disease. Despite being a relatively new drug used in veterinary medicine, some equine practitioners are already prescribing tiludronate for “off-label” use in horses with other conditions, such as osteoarthritis by ...

BloodHorse.com Race Result Alerts

BloodHorse.com Race Result Alerts

Once you are registered with BloodHorse.com, you can choose to receive varying email alerts! Click here to sign up for race result alerts now!

TOBA November Member of the Month

  • TOBA
TOBA November Member of the Month

Leading the pack of Ohio breeders is Robin L. Murphy, who stands nearly a dozen stallions at her 80-acre Poplar Creek Horse Center in Bethel, Ohio.

Equine Venereal Disease

STDs. They're the kind of thing many people would rather not discuss. Disease transmission through sexual contact or bodily fluids such as semen and blood is still a taboo subject, even in 2012. But the reality is that as long as horse owners continue to breed their mares to stallions hundreds or thousands of miles away--or to stallions who are in the...

Ol' Fashion Gal Upsets Jimmy Durante

Ol' Fashion Gal Upsets Jimmy Durante

Squeezing through a tight opening along the rail in mid-stretch, Ol' Fashion Gal prevailed over favored Rainha Da Bateria to upset the $151,500 Jimmy Durante Stakes (gr. IIIT) Nov. 29 at Del Mar.

News By Topic

News By Date

PrevNext
December 2014
SuMoTuWeThFrSa
 123456
78910111213
14151617181920
21222324252627
28293031   

Most Popular Stories

Special Offer

The Blood-Horse

Get 8 FREE issues of The Blood-Horse!

Don’t miss a minute of the action...with 8 FREE issues of The Blood-Horse. And if you like them, you can continue with a full year of issues and get the next edition of the Stallion Register, plus complete coverage of the Kentucky Derby and Breeders' Cup World Championships. Click here to learn more.